Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Levonorgestrel/medroxyprogesterone

Lack of efficacy: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hirata T, et al. Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer. Journal of Obstetrics and Gynaecology Research 48 : 3219-3225, No. 12, Dec 2022. Available from: URL: http://doi.org/10.1111/jog.15408 Hirata T, et al. Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer. Journal of Obstetrics and Gynaecology Research 48 : 3219-3225, No. 12, Dec 2022. Available from: URL: http://​doi.​org/​10.​1111/​jog.​15408
Metadaten
Titel
Levonorgestrel/medroxyprogesterone
Lack of efficacy: 4 case reports
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44021-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Adalimumab

Case report

Nivolumab

Case report

Multiple drugs